首页 工具
登录
全部产品 抑制剂&激动剂 化合物库 天然产物 技术服务 重组蛋白 会员中心 联系我们
购物车
抑制剂&激动剂 血管生成 凋亡 自噬 细胞周期 表观遗传 细胞骨架 DNA损伤和修复 内分泌与激素 G蛋白偶联受体 免疫与炎症 JAK/STAT信号通路 MAPK信号通路 离子通道 代谢 微生物学 神经科学
化合物库 活性化合物库 •   通用已知活性库 •   上市状态分类 •   疾病类型分类 •   通路靶点分类 天然产物库 •   高通量筛选天然产物库 •   特色天然产物库 •   天然产物衍生物库 Fragment片段库 •   通用片段库 •   特色片段库 类药性化合物库 •   多样性核心库Part2 •   多样性核心库Part1 化合物库深度定制
技术服务 计算机辅助药物设计 •   虚拟筛选 实体化合物活性筛选 •   分子结合&互作检测 药物设计和结构优化 天然产物 试剂盒 Cell Counting Kit-8 (CCK-8) Inhibitor Cocktails SYBR Green qPCR Master Mix (No ROX) 染料试剂 多肽产品 抗体抑制剂 PROTAC
重组蛋白 细胞因子和生长因子 •   细胞因子 •   生长因子 受体蛋白 •   Fc 受体 •   细胞因子和生长因子受体 •   受体酪氨酸激酶 CD 蛋白 •   T 细胞 CD 蛋白 •   B 细胞 CD 蛋白 免疫检查点蛋白 •   抑制性免疫检查点蛋白 •   刺激性免疫检查点蛋白 CAR-T 细胞治疗靶点蛋白 •   血液恶性肿瘤靶点蛋白 •   实体瘤靶点蛋白
信号通路 血管生成 凋亡 自噬 细胞周期 表观遗传 细胞骨架
DNA损伤和修复 内分泌与激素 G蛋白偶联受体 免疫与炎症 JAK/STAT信号通路 MAPK信号通路 离子通道
代谢 微生物学 神经科学 NF-κB信号通路 氧化还原 PI3K/Akt/mTOR信号通路 蛋白酶体
干细胞 蛋白酪氨酸激酶 泛素化 PROTAC 其他
活性化合物库 上市药物库 临床期小分子药物库 已知活性化合物库 FDA上市及药典收录分子库 抗癌药物库 抗病毒库 铁死亡化合物库
天然产物库 高通量筛选天然产物库 Ro5类药天然产物库 中药单体化合物库 糖类及苷类化合物库 稀有天然产物库 天然产物衍生物库 天然产物单体化合物库
Fragment片段库 高溶解性片段库 精选片段库 高溶解性多官能团片段化合物库 高溶解性卤化片段化合物库 药物片段库 Mini片段亲电杂环化合物库 高溶解性微型片段化合物库
类药性化合物库 多样性核心库Part2 多样性核心库Part1 药物靶点库 多样性核心预制库 Golden骨架库 Mini骨架库 化合物库深度定制
TargetMol Compound Library
天然产物库 高通量筛选天然产物库 特色天然产物库 天然产物衍生物库 虚拟筛选天然产物库
结构类型 萜类 类固醇 类黄酮 醌类 香豆素 木脂素 多糖和糖苷
苯丙烷 生物碱 酚类 其他
植物来源 列当科 水龙骨科 南洋杉科 报春花科 海金沙科 商陆科 买麻藤科
萝藦科 肉豆蔻科 鸭跖草科 交让木科 三白草科 海桐花科 五味子科 红厚壳科
莲叶桐科 胡桃科 石杉科 桔梗科 百合科 忍冬科 漆树科
计算机辅助药物设计 虚拟筛选 分子对接 反向找靶 分子动力学模拟
基于靶点筛选实体化合物活性筛选 分子结合&互作检测 酶学靶点活性检测 核受体靶点活性检测 GPCR靶点活性检测
基于表型筛选实体化合物活性筛选 细胞增殖检测 细胞周期检测 细胞凋亡检测 药代动力学研究
药物设计和结构优化 化合物定制合成 分子砌块 网络药理学平台 软件平台
细胞因子和生长因子 •   细胞因子 •   生长因子 受体蛋白 •   Fc 受体 •   细胞因子和生长因子受体
CD 蛋白 •   T 细胞 CD 蛋白 •   B 细胞 CD 蛋白 免疫检查点蛋白 •   抑制性免疫检查点蛋白 •   刺激性免疫检查点蛋白
CAR-T 细胞治疗靶点蛋白 •   血液恶性肿瘤靶点蛋白 •   实体瘤靶点蛋白 酶 •   氧化还原酶 •   转移酶
病毒蛋白 •   冠状病毒蛋白 •   流感病毒蛋白 荧光蛋白 其他蛋白

搜索结果

Search Results for " fr a "

97

抑制剂 & 化合物

10

天然产物

142

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T27388 FR-A 19

FR-A-19,FRA19
FR-A 19, a Histamine H2 agonist, inhibits the release of IgE-mediated human basophil histamine in a nanomolar range. It has additional potent anti-allergic properties.
T70277 Cynandione A

Others Others
Cynandione A 是从 Cynanchum wilfordii 中提取的苯乙酮，具有抗炎活性，可通过巨噬细胞 α7 nAChR 激活和随后的 IL-10 表达来显着减少促炎细胞因子的过表达。
T24053 WS 009A

WS009 A,FR 901366,WS009A,WS-009A
WS 009A is an antagonist of the endothelin receptor.
T22790 FR 122047

4,5-Bis(4-methoxyphenyl-2-[(1-methylpiperazin-4-yl)carbonyl]thiazole, Hydrochloride,1-[(4,5-Bis(4-methoxyphenyl-2-thiazoyl)carbonyl]-4-methylpiperazine, Hydrochloride,FR 122047盐酸盐

 COX Immunology/Inflammation; Neuroscience
FR 122047 (1-[(4,5-Bis(4-methoxyphenyl-2-thiazoyl)carbonyl]-4-methylpiperazine, Hydrochloride) 是一种口服有活性的、选择性的 COX-1 抑制剂（IC50:28 nM）。它在体内具有镇痛、抗炎、抗血小板的功能。
Fr13755 5-Fluoroisatin

5-氟靛红
Compound Fr13755 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13755，CAS号为 443-69-6。
T9468 FR054

Others Others
FR054 是一种己糖胺生物合成途径酶 PGM3 的抑制剂，具有明显的抗乳腺癌活性。它在不同的乳腺癌细胞中诱导细胞增殖和存活显著降低。
Fr14145 4-Hydroxyphenylacetamide

Compound Fr14145 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr14145，CAS号为 17194-82-0。
Fr13375 (-)-Paroxol

trans-Paroxol
Compound Fr13375 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13375，CAS号为 105812-81-5。
Fr13199 4-(4-chlorophenyl)piperidin-4-ol

Compound Fr13199 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13199，CAS号为 39512-49-7。
Fr13734 Piperonylonitrile

1,3-Benzodioxole-5-carbonitrile
Compound Fr13734 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13734，CAS号为 4421-09-4。
T1956 FR 180204

FR180204

 Apoptosis; ERK Apoptosis; MAPK
FR 180204 是一种 ATP 竞争性的选择性ERK 抑制剂，对ERK1和ERK2的Ki 值分别为 0.31 μM 和 0.14 μM，IC50值分别为0.51 μM 和0.33 μM。
T27371 FR-167356

FR167356,FR 167356

 ATPase Membrane transporter/Ion channel
FR-167356 是 a3 异构体液泡型 H+-ATPase 的特异性抑制剂，对破骨细胞质膜、肾刷状缘膜和巨噬细胞微粒体的 IC50 分别为 170 nM、370 nM 和 220 nM。 FR-167356 减少 B16-F10 细胞的骨转移。
T11319 FR183998 free base

Na+/Ca2+ Exchanger Membrane transporter/Ion channel
FR183998 free base 是 Na+/Ca2+ 交换剂的抑制剂。
Fr14055 Pyridin-4-ol

Compound Fr14055 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr14055，CAS号为 626-64-2。
Fr12380 Benzothiazole-6-carboxylic acid

Compound Fr12380 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr12380，CAS号为 3622-35-3。
Fr14035 3,3-Tetramethyleneglutarimide

Compound Fr14035 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr14035，CAS号为 1075-89-4。
Fr12729 1-Benzyl-4-hydroxypiperidine

1-Benzylpiperidin-4-ol
Compound Fr12729 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr12729，CAS号为 4727-72-4。
Fr12428 7-Chloro-3H-quinazolin-4-one

7-Chloro-3H-quinazolin-4-one 是一种片段分子，在生命科学相关研究中具有广泛的应用。
Fr12622 (2-butyl-4-chloro-1H-imidazol-5-yl)methanol

Compound Fr12622 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr12622，CAS号为 79047-41-9。
Fr13901 Methyl 3-amino-4-methylbenzoate

Compound Fr13901 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13901，CAS号为 18595-18-1。
Fr14015 4-Methylquinolin-2-ol

2-Hydroxy-4-methylquinoline
Compound Fr14015 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr14015，CAS号为 607-66-9。
Fr14428 3-Amino-4-methylbenzoic acid

Compound Fr14428 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr14428，CAS号为 2458-12-0。
Fr13736 4-Phenylimidazole

5-Phenyl-1H-imidazole
Compound Fr13736 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13736，CAS号为 670-95-1。
Fr13634 4-Aminobenzamide

红色基DB-70
Compound Fr13634 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13634，CAS号为 2835-68-9。
Fr16627 3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine

Compound Fr16627 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr16627，CAS号为 20348-23-6。
Fr12564 5-Chloro-2-methoxybenzoic acid

5-Chloro-o-anisic acid
Compound Fr12564 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr12564，CAS号为 3438-16-2。
Fr13877 H-DL-Gly-OBzl HCl

Compound Fr13877 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13877，CAS号为 2462-31-9。
Fr12480 3-(dimethylamino)-1-(thiophen-2-yl)propan-1-one HCl

3-(dimethylamino)-1-(thiophen-2-yl)propan-1-one HCl 是一种片段分子，在生命科学相关研究中具有广泛的应用。
Fr13623 Benzofuran-2-carboxylic acid

Compound Fr13623 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13623，CAS号为 496-41-3。
Fr14565 2,4-DIMETHYLTHIAZOLE

2,4-Dimethyl-1,3-thiazole
Compound Fr14565 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr14565，CAS号为 541-58-2。
Fr13619 2-ANILINOETHANOL

Compound Fr13619 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13619，CAS号为 122-98-5。
Fr12535 2-(Trifluoromethyl)benzimidazole

Compound Fr12535 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr12535，CAS号为 312-73-2。
Fr13857 4-chlorofuro[3,2-c]pyridine

Compound Fr13857 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr13857，CAS号为 31270-80-1。
T11321 FR194738 free base

Antifungal Microbiology/Virology
FR194738 free base 抑制 HepG2 细胞匀浆中的角鲨烯环氧酶活性，IC50 为 9.8 nM。
T8934 (6R)-FR054

(3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐,FR054

 Apoptosis; Others Apoptosis; Others
(6R)-FR054 是己糖胺生物合成途径酶 PGM3 的抑制剂，具有显著的抗乳腺癌作用。
TP1682L Abz-FR-K(Dnp)-P-OH acetate(500799-61-1 free base)

Others Others
Abz-FR-K(Dnp)-P-OH acetate(500799-61-1 free base) 是一种出色的血管紧张素 I 转换酶 (ACE) 底物，Km 值为 4.0 μM，kcat 值为 210s-1。
T35700 FR901379

FR901379 is an echinocandin-like antifungal lipopeptide.1 It is active against C. albicans, C. krusei, C. tropicalis, C. utilis, A. fumigatus, and A. niger fungi (IC50s = <0.003-1.9 μg/ml). FR901379 is protective against C. albicans infection in mice (ED50 = 1.1 mg/kg). It also reduces the number of pulmonary cysts and trophozoites in a mouse model of P. carinii infection. |1. Fujie, A., Iwamoto, T., Sato, B., et al. FR131535, a novel water-soluble echinocandin-like lipopeptide: Synthesis and bi...
T36024 FR179642 (hydrate)

FR179642 (hydrate)
FR179642 is the cyclic peptide nucleus of the lipopeptide antifungal FR901379 and an intermediate in the synthesis of the echinocandin antifungal FK463 .1,2 1.Tomishima, M., Ohki, H., Yamada, A., et al.FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activityJ. Antibiot. (Tokyo)52(7)674-676(1999) 2.Ueda, S., Shibata, T., Ito, K., et al.Cloning and expression of the FR901379 acylase gene from Streptomyces sp. no. 6907J. Antibiot. (Tokyo)64(2)169-175(2011)
T71614 FR 900452

FR 900452 is a platelet activating factor antagonist from fermentatiion products of Streptomyces phaeofaciens.
T35740 FR900098 (sodium salt)

FR900098 is a derivative of fosmidomycin that has antimalarial activity (IC50s = 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively). FR900098 inhibits DOXP reductoisomerase, a key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis, in vitro in a dose-dependent manner. FR900098 (>10 mg/kg, i.p.) eradicated P. vinckei parasites within four days in mice.
T70969 FR 111142

FR 111142 is an angiogenesis inhibitor produced by the fungus Scolecobasidium arenarium.
Fr12310 (S)-1-Benzylpyrrolidin-3-ol

Compound Fr12310 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 Fr12310，CAS号为 101385-90-4。
T68972 FR-7534

FR-7534 is a calcium antagonist structurally similar to nifedipine.
T69402 FR-226928

FR-226928 is a potent antagonist of human neuropeptide Y Y5 receptors.
T68619 FR-48217

FR-48217 is an immunoactive peptide that inhibits multiplication of HSV-1 and HSV-2.
T70274 FR171456

FR171456 is a natural specific inhibitor of mammalian nsdhl and yeast erg26p, inhibiting an artificial hepatitis c viral replicon, and showung broad antifungal activity
T62828 FRα-IN-1

FRα-IN-1 (Compound 4) 是一种肿瘤靶向剂。FRα-IN-1 对 FRα 和 FRβ 表达细胞表现出选择性的抗癌效果。
T11320 FR194738

Antifungal Microbiology/Virology
FR194738 是一种角鲨烯环氧酶抑制剂，在 HepG2 细胞匀浆中的 IC50 为 9.8 nM。
Fr16605L Lupinine hydrochloride

Lupinine hydrochloride is a bioactive chemical.
T68732 FR-226928 free base

FR-226928 free base is a potent antagonist of human neuropeptide Y Y5 receptors.

化合物

FR-A 19
Cat.No: T27388
Synonym: FR-A-19,FRA19
Target:
Cynandione A
Cat.No: T70277
Synonym:
Target: Others
WS 009A
Cat.No: T24053
Synonym: WS009 A,FR 901366,WS009A,WS-009A
Target:
FR 122047
Cat.No: T22790
Synonym: 4,5-Bis(4-methoxyphenyl-2-[(1-methylpiperazin-4-yl)carbonyl]thiazole, Hydrochloride,1-[(4,5-Bis(4-methoxyphenyl-2-thiazoyl)carbonyl]-4-methylpiperazine, Hydrochloride,FR 122047盐酸盐
Target: COX
5-Fluoroisatin
Cat.No: Fr13755
Synonym: 5-氟靛红
Target:
FR054
Cat.No: T9468
Synonym:
Target: Others
4-Hydroxyphenylacetamide
Cat.No: Fr14145
Synonym:
Target:
(-)-Paroxol
Cat.No: Fr13375
Synonym: trans-Paroxol
Target:
4-(4-chlorophenyl)piperidin-4-ol
Cat.No: Fr13199
Synonym:
Target:
Piperonylonitrile
Cat.No: Fr13734
Synonym: 1,3-Benzodioxole-5-carbonitrile
Target:
FR 180204
Cat.No: T1956
Synonym: FR180204
Target: Apoptosis, ERK
FR-167356
Cat.No: T27371
Synonym: FR167356,FR 167356
Target: ATPase
FR183998 free base
Cat.No: T11319
Synonym:
Target: Na+/Ca2+ Exchanger
Pyridin-4-ol
Cat.No: Fr14055
Synonym:
Target:
Benzothiazole-6-carboxylic acid
Cat.No: Fr12380
Synonym:
Target:
3,3-Tetramethyleneglutarimide
Cat.No: Fr14035
Synonym:
Target:
1-Benzyl-4-hydroxypiperidine
Cat.No: Fr12729
Synonym: 1-Benzylpiperidin-4-ol
Target:
7-Chloro-3H-quinazolin-4-one
Cat.No: Fr12428
Synonym:
Target:
(2-butyl-4-chloro-1H-imidazol-5-yl)methanol
Cat.No: Fr12622
Synonym:
Target:
Methyl 3-amino-4-methylbenzoate
Cat.No: Fr13901
Synonym:
Target:
4-Methylquinolin-2-ol
Cat.No: Fr14015
Synonym: 2-Hydroxy-4-methylquinoline
Target:
3-Amino-4-methylbenzoic acid
Cat.No: Fr14428
Synonym:
Target:
4-Phenylimidazole
Cat.No: Fr13736
Synonym: 5-Phenyl-1H-imidazole
Target:
4-Aminobenzamide
Cat.No: Fr13634
Synonym: 红色基DB-70
Target:
3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
Cat.No: Fr16627
Synonym:
Target:
5-Chloro-2-methoxybenzoic acid
Cat.No: Fr12564
Synonym: 5-Chloro-o-anisic acid
Target:
H-DL-Gly-OBzl HCl
Cat.No: Fr13877
Synonym:
Target:
3-(dimethylamino)-1-(thiophen-2-yl)propan-1-one HCl
Cat.No: Fr12480
Synonym:
Target:
Benzofuran-2-carboxylic acid
Cat.No: Fr13623
Synonym:
Target:
2,4-DIMETHYLTHIAZOLE
Cat.No: Fr14565
Synonym: 2,4-Dimethyl-1,3-thiazole
Target:
2-ANILINOETHANOL
Cat.No: Fr13619
Synonym:
Target:
2-(Trifluoromethyl)benzimidazole
Cat.No: Fr12535
Synonym:
Target:
4-chlorofuro[3,2-c]pyridine
Cat.No: Fr13857
Synonym:
Target:
FR194738 free base
Cat.No: T11321
Synonym:
Target: Antifungal
(6R)-FR054
Cat.No: T8934
Synonym: (3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐,FR054
Target: Apoptosis, Others
Abz-FR-K(Dnp)-P-OH acetate(500799-61-1 free base)
Cat.No: TP1682L
Synonym:
Target: Others
FR901379
Cat.No: T35700
Synonym:
Target:
FR179642 (hydrate)
Cat.No: T36024
Synonym: FR179642 (hydrate)
Target:
FR 900452
Cat.No: T71614
Synonym:
Target:
FR900098 (sodium salt)
Cat.No: T35740
Synonym:
Target:
FR 111142
Cat.No: T70969
Synonym:
Target:
(S)-1-Benzylpyrrolidin-3-ol
Cat.No: Fr12310
Synonym:
Target:
FR-7534
Cat.No: T68972
Synonym:
Target:
FR-226928
Cat.No: T69402
Synonym:
Target:
FR-48217
Cat.No: T68619
Synonym:
Target:
FR171456
Cat.No: T70274
Synonym:
Target:
FRα-IN-1
Cat.No: T62828
Synonym:
Target:
FR194738
Cat.No: T11320
Synonym:
Target: Antifungal
Lupinine hydrochloride
Cat.No: Fr16605L
Synonym:
Target:
FR-226928 free base
Cat.No: T68732
Synonym:
Target:
Cat. No. Product Name Target Signaling Pathways
Fr16683 2,6-Dihydroxyacetophenone

Compound Fr16683 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 Fr16683，CAS号为 699-83-2。
Fr16664 Benzothiazolone

2-Benzothiazolol
Compound Fr16664 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 Fr16664，CAS号为 934-34-9。
T31866 FR901464

FR 901464,FR-901464,WB 2663B

 Others Others
FR901464 (WB 2663B)是具有强细胞毒性的天然产物，共享一个含胺的四氢吡喃环。
Fr14273 2'-Aminoacetophenone

Compound Fr14273 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 Fr14273，CAS号为 551-93-9。
Fr14500 2,3,5-Trimethylpyrazine

Compound Fr14500 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 Fr14500，CAS号为 14667-55-1。
T39148 FR179642

FR179642
FR179642 is an essential intermediate compound utilized in the synthesis of Micafungin, an antifungal drug belonging to the echinocandin class. It serves as the cyclic peptide foundation for the structurally similar antifungal lipopeptide FR901379.
T41346 9-Demethyl FR-901235

9-Demethyl FR-901235 FR-901235 的去甲基形式，FR-901235 是一种免疫活性物质。
T3S1960 Kakuol

Antifungal Microbiology/Virology
Kakuol 是一种有抗真菌活性的天然产物。
T27380 FR-198248

FR-198248, a new anti-influenza agent, shows antiinfluenza virus activity in Madin-Darby canine kidney (MDCK) cells in vitro.
TN2456 Lucidone A

Others Others
Lucidone A is a natural product from Ganoderma lucidum (Leyss. Ex Fr.) Karst.

天然产物

2,6-Dihydroxyacetophenone
Cat.No: Fr16683
Synonym:
Target:
Benzothiazolone
Cat.No: Fr16664
Synonym: 2-Benzothiazolol
Target:
FR901464
Cat.No: T31866
Synonym: FR 901464,FR-901464,WB 2663B
Target: Others
2'-Aminoacetophenone
Cat.No: Fr14273
Synonym:
Target:
2,3,5-Trimethylpyrazine
Cat.No: Fr14500
Synonym:
Target:
FR179642
Cat.No: T39148
Synonym: FR179642
Target:
9-Demethyl FR-901235
Cat.No: T41346
Synonym:
Target:
Kakuol
Cat.No: T3S1960
Synonym:
Target: Antifungal
FR-198248
Cat.No: T27380
Synonym:
Target:
Lucidone A
Cat.No: TN2456
Synonym:
Target: Others
Species：
Human (138)
Human & Mouse (4)
Expression System：
HEK293 Cells (126)
E. coli (16)
Tag：
C-His-Avi (139)
C-His (1)
N-His (1)
N-His-Avi (1)
Cat. No. Product Name Species Expression System
TMPK-00150 FOLR1 Protein, Human, Recombinant (His & Avi)

Folate receptor 1,Folbp1,Folate receptor <...

 Human HEK293 Cells
Folate Receptor 1 (FOLR1), also known as Folate Receptor alpha and Folate Binding Protein (FBP), is a 37 - 42 kDa protein that mediates the cellular uptake of folic acid and reduced folates. Dietary folates are required for many key metabolic processes including nucleotide and methionine synthesis, the interconversion of glycine and serine, and histidine breakdown. FOLR1 binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into t...
TMPY-00585 Annexin A8 Protein, Human, Recombinant (His)

ANX8,annexin A8

 Human E. coli
We have previously shown that Annexin A8 (ANXA8) is strongly associated with the basal-like subgroup of breast cancers, including BRCA1-associated breast cancers, and poor prognosis; while in the mouse mammary gland AnxA8 mRNA is expressed in low-proliferative isolated pubertal mouse mammary ductal epithelium and after enforced involution, but not in isolated highly proliferative terminal end buds (TEB) or during pregnancy. ANXA8 as a potential mediator of quiescence in the normal mouse mammary ...
TMPK-01426 Peptide Ready HLA-A*11:01&B2M Monomer Protein, Human, MHC (His & Avi)

HLA-A*02:01,Peptide Ready,MHC

 Human HEK293 Cells
Peptide Ready HLA-A*11:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*11:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01419 Peptide Ready HLA-A*03:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated

MHC,HLA-A*02:01,Peptide Ready

 Human HEK293 Cells
Peptide Ready HLA-A*03:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*03:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01421 Peptide Ready HLA-A*02:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated

HLA-A*02:01,MHC,Peptide Ready

 Human HEK293 Cells
HLA-A*02:01&B2M&Peptide ready Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01420 Peptide Ready HLA-A*03:01&B2M Monomer Protein, Human, MHC (His & Avi)

Peptide Ready,MHC,HLA-A*02:01

 Human HEK293 Cells
Peptide Ready HLA-A*03:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*03:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01422 Peptide Ready HLA-A*02:01&B2M Monomer Protein, Human, MHC (His & Avi)

Peptide Ready,MHC,HLA-A*02:01

 Human HEK293 Cells
Peptide Ready HLA-A*02:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01425 Peptide Ready HLA-A*11:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated

MHC,HLA-A*02:01,Peptide Ready

 Human HEK293 Cells
Peptide Ready HLA-A*11:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*11:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01410 Peptide Ready HLA-A*24:02&B2M Monomer Protein, Human, MHC (His & Avi)

HLA-A,MHC,Peptide Ready

 Human HEK293 Cells
Peptide Ready HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01409 Peptide Ready HLA-A*24:02&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated

Peptide Ready,MHC,HLA-A

 Human HEK293 Cells
Peptide Ready HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01415 APC-equivalent Peptide Ready HLA-A*02:01&B2M Tetramer Protein, Human, MHC (His)

Peptide Ready,HLA-A*02:01,MHC

 Human HEK293 Cells
Peptide Ready HLA-A*02:01&B2M Tetramer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01427 HLA-A*11:01&B2M&KRAS G12D (VVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated

C-K-RAS,K-RAS4B,GTPase Kra

Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01403 HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)

K-Ras 2,KI-RAS,CFC2,KRAS1,GTP...

 Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01448 HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein, Human, MHC (E. coli, His & Avi)

MHC,LAGE-2,NY-ESO-1,ESO1CTAG,MY-ESO-1,CT

Human E. coli
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01399 HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated

K-RAS2A,NS3,KRAS2,CFC2,K-RA

Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01404 HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated

NS,KRAS,KRAS1,KRAS2,MHC,RA

Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01467 HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, Human, MHC (His & Avi)

HPV16,E6,Human papillomavirus typ...

 Human HEK293 Cells
Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer.
TMPK-01479 HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated

NS3,KRAS1,K-Ras 2,K-RAS2A

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01520 HLA-A*02:01&B2M&AFP (PLFQVPEPV) Tetramer Protein, Human, MHC (His & Avi)

Alpha-1-fetoprotein,AFP,HPA

Human HEK293 Cells
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01444 HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Tetramer Protein, Human, MHC (His & Avi)

MZ2-E,MAGE1A,MAGE-1 anti...

 Human HEK293 Cells
MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors.
TMPK-01474 HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi)

Human HEK293 Cells
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa.
TMPK-01470 HLA-A*02:01&B2M&MAGE-A4 or MAGE-A8 (KVLEHVVRV) Monomer Protein, Human, MHC (His & Avi)

MAGE-A4 or MAGE-A8,M...

 Human HEK293 Cells
MAGE-A4 and MAGE-A8 are type I membes of the melanoma associated antigen (MAGE) family. The MAGE family is a large, highly conserved group of proteins that share a common MAGE homology domain. Both MAGE-A4 and MAGE-A8 antigen-presenting peptides can be presented by HLA-A*02:01.
TMPK-01525 HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated

CFC2,RALD,K-Ras 2,MHC,C-K-RAS,NS3...

 Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01461 HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein, Human, MHC (His & Avi)

C-K-RAS,KRAS,RASK2,K-Ras...

 Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01434 HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer Protein, Human, MHC (His & Avi)

RASK2,CFC2,GTPase Kras,KRA

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01417 HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled

Alpha-1-fetoprotein,HPAFP,A

Human HEK293 Cells
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01446 HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein, Human, MHC (His & Avi)

MAGE1,MAGE1A,MAGE-1 ...

 Human HEK293 Cells
MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors.
TMPK-01494 HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Tetramer Protein, Human, MHC (His & Avi)

HLA-A,HLA-A*0101,HLA...

 Human HEK293 Cells
Cancer/testis antigens 83 (CT83), also called KK-LC-1 or CXorf61, recognized by cytotoxic T lymphocytes (CTL), has become a promising target for immunotherapy.
TMPK-01481 HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Monomer Protein, Human, MHC (His & Avi), Biotinylated

svn 2B,svn-2B,Survivin-2B

 Human HEK293 Cells
Survivin-2B, a known splice variant of survivin, has been reported to promote cell death in some cancer cells, although it keeps prosurvival function in others.survivin-2B promoted autophagy and further regulated cell death by accumulating and stabilizing IKK alpha in the nucleus.
TMPK-01530 HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein, Human, MHC (His & Avi), Biotinylated

MHC,LMP-2,PSMB9,LMP2,Macropain cha

Human HEK293 Cells
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of ma...
TMPK-01519 HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi)

MHC,FETA,AFP,Alpha-feto,...

 Human HEK293 Cells
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01513 HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi), Biotinylated

CT6.1,LAGE2A,MHC,CTAG1B,CTA

Human HEK293 Cells
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01408 HLA-A*02:01&B2M&KRAS G12V (KLVVVGAVGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated

RALD,KRAS1,KRAS2,K-RAS2B...

 Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01401 HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)

MHC,CFC2,K-Ras 2,RALD,K-RAS4A...

 Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01429 HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated

MHC,K-Ras 2,NS,K-RAS4A,KRA

Human E. coli
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01449 HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Human, MHC (E. coli, His & Avi)

MHC,CT6.1,CTAG1,LAGE-2,MY-ESO-1,NY-ESO-1,E...

 Human E. coli
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01473 HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi), Biotinylated

CT1.3,MAGE-3,MZ2-D,MZ2D,HLA-A2402...

 Human HEK293 Cells
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa.
TMPK-01488 HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)

K-RAS4A,MHC,GTPase Kras,...

 Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01445 HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein, Human, MHC (His & Avi), Biotinylated

CT1.1,MAGE1,MAGE-1,MAGE-A

Human HEK293 Cells
MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors.
TMPK-01529 HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi)

K-RAS4A,KRAS1,MHC,K-RAS2...

 Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01455 HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein, Human, MHC (His & Avi)

OIP4,PRAME,OIP-4,MAPE

 Human HEK293 Cells
PRAME (PReferentially expressed Antigen in MElanoma) is a melanoma-associated antigen expressed in cutaneous and ocular melanomas and some other malignant neoplasms, while its expression in normal tissue and benign tumors is limited.
TMPK-01458 HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi)

K-Ras 2,GTPase Kras,KRAS...

 Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01463 HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi)

C-K-RAS,KI-RAS,KRAS1,K-RA

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01477 HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His & Avi), Biotinylated

HPAFP,FETA,Alpha-1-fetop...

 Human HEK293 Cells
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01442 HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled

HLA-A,P53,TP53,LFS1,MHC,BCC7,TRP53,FLJ9294...

 Human HEK293 Cells
p53 is a tumor suppressor protein. Under stressful conditions, p53 tightly regulates cell growth by promoting apoptosis and DNA repair. When p53 becomes mutated, it loses its function, resulting in abnormal cell proliferation and tumor progression. Depending on the p53 mutation, it has been shown to form aggregates leading to negative gain of function of the protein. p53 mutant associated aggregation has been observed in several cancer tissues and has been shown to promote tumor growth.
TMPK-01518 HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)

MHC,NS,KRAS1,K-RAS2A,GTPa

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01480 HLA-A*02:01&B2M&Survivin (LMLGEFLKL) Monomer Protein, Human, MHC (His & Avi), Biotinylated

IAP4,Survivin,API4,BIRC5,MHC,MHC I,EPR-1,s...

 Human HEK293 Cells
Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target.
TMPK-01527 HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)

NS,RALD,C-K-RAS,RASK2,K-RA

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01500 HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi)

CTAG1,CT6.1,CTAG1B,LAGE2A

Human HEK293 Cells
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01539 HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Human, MHC (His & Avi), Biotinylated

CTAG1B,CT6.1,MY-ESO-1,LAGE2A,NY-E...

 Human HEK293 Cells
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
------------------------ 更多 ------------------------

重组蛋白

FOLR1 Protein, Human, Recombinant (His & Avi)
Cat.No: TMPK-00150
Species: Human
Expression System: HEK293 Cells
Annexin A8 Protein, Human, Recombinant (His)
Cat.No: TMPY-00585
Species: Human
Expression System: E. coli
Peptide Ready HLA-A*11:01&B2M Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01426
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*03:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01419
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*02:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01421
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*03:01&B2M Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01420
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*02:01&B2M Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01422
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*11:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01425
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*24:02&B2M Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01410
Species: Human
Expression System: HEK293 Cells
Peptide Ready HLA-A*24:02&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01409
Species: Human
Expression System: HEK293 Cells
APC-equivalent Peptide Ready HLA-A*02:01&B2M Tetramer Protein, Human, MHC (His)
Cat.No: TMPK-01415
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12D (VVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01427
Species: Human
Expression System: E. coli
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)
Cat.No: TMPK-01403
Species: Human
Expression System: E. coli
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein, Human, MHC (E. coli, His & Avi)
Cat.No: TMPK-01448
Species: Human
Expression System: E. coli
HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01399
Species: Human
Expression System: E. coli
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
Cat.No: TMPK-01404
Species: Human
Expression System: E. coli
HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01467
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01479
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&AFP (PLFQVPEPV) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01520
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01444
Species: Human
Expression System: HEK293 Cells
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01474
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&MAGE-A4 or MAGE-A8 (KVLEHVVRV) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01470
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01525
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01461
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01434
Species: Human
Expression System: HEK293 Cells
HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
Cat.No: TMPK-01417
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01446
Species: Human
Expression System: HEK293 Cells
HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01494
Species: Human
Expression System: HEK293 Cells
HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01481
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01530
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01519
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01513
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&KRAS G12V (KLVVVGAVGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01408
Species: Human
Expression System: E. coli
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)
Cat.No: TMPK-01401
Species: Human
Expression System: E. coli
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
Cat.No: TMPK-01429
Species: Human
Expression System: E. coli
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Human, MHC (E. coli, His & Avi)
Cat.No: TMPK-01449
Species: Human
Expression System: E. coli
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01473
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01488
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01445
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01529
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01455
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01458
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01463
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01477
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
Cat.No: TMPK-01442
Species: Human
Expression System: HEK293 Cells
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01518
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&Survivin (LMLGEFLKL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01480
Species: Human
Expression System: HEK293 Cells
HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01527
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01500
Species: Human
Expression System: HEK293 Cells
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01539
Species: Human
Expression System: HEK293 Cells
--------- 更多 ---------
共97条，每页50条 1 2
TargetMol®
关于我们 隐私声明 前沿资讯 相关条款
相关支持
联系我们 全球经销商 订购指南 技术支持
技术资源
产品目录 产品引用文献 信号通路 溶液计算器
订阅 TargetMol®
订阅以获得我们的产品更新和特惠活动!
获取我们的最新产品和特惠活动!
TargetMol®
相关支持
技术资源
我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。
Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4 沪公网安备 31010602006700号 沪公网安备 31010602006700号
联系我们
400-820-0310
service@tsbiochem.com
2881945090（终端用户）
2885109491（经销商） 

上海市静安区江场三路238号8楼